Summary
The features and treatment of 98 Chinese patients with immunoglobulin G4 (IgG4)-related disease (IgG4-RD) referred to a single tertiary referring centre were reviewed. Patients diagnosed with IgG4-RD according to the comprehensive diagnostic criteria (CDC) were included in the retrospective study from May 2012 to March 2019. We collected data on clinical, laboratory, imaging, histological features and treatment. Totally, 98 patients with IgG4-RD were enrolled. The common clinical manifestations included abdominal pain, salivary gland swelling and lymphadenopathy. 51% of the patients had multiple organs involvement. Lymph nodes, pancreas and salivary glands were most commonly involved. Four rare sites including ulna, cerebellum, scalp, and mammary gland were found. The serum IgG4 level was increased by 85.7%. The serum IgG4 level was positively correlated with the number of involved organs, IgG and IgG4/IgG. Low C3 and C4 levels were observed in 37.5% and 12.2% patients respectively, and all patients with kidney involvement had hypocomplementemia. A total of 54 patients underwent tissue biopsies, and 55.6%, 31.5% and 11.1% cases were diagnosed as definite, probable and possible IgG4-RD, respectively. Eighty-eight patients received glucocorticoids (GCs) therapy. Five patients underwent radical surgery to remove the lesion. 73% of them presented a complete or partial remission. IgG4-RD is a systemic fibroinflammatory disease with involvement of multiple organs throughout the body including some rare sites. Most IgG4-RD patients had increased serum IgG4 levels and patients with kidney involvement showed hypocomplementemia. GCs therapy is effective. More research is needed to provide a more reliable basis for the diagnosis and treatment of patients.
Similar content being viewed by others
References
Stone JH, Zen Y, Deshpande V. IgG4 related disease. N Engl J Med, 2012,366(6):539–551
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol, 2012,22(1):21–30
Rotondi M, Carbone A, Coperchini F, et al. Diagnosis of Endocrine Disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol, 2019,180(5):R175–R183
Lee CW, Ronnekleiv-Kelly S. Autoimmune Diseases of the Biliary Tract: A Review. Surg Clin North Am, 2019, 99(2):185–201
Detiger SE, Karim AF, Verdijk RM, et al. The treatment outcomes in IgG4-related orbital disease: a systematic review of the literature. Acta Ophthalmol, 2019,97(5):451–459.
Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol, 2006, 16(6):335–340
Khosroshahi A, Wallace ZS, Crowe JL, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol, 2015,67(7):1688–1699
Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut, 2009,58(11):1504–1507
Iaccarino L, Talarico R, Scirè CA, et al. IgG4-related diseases state of the art on clinical practice guidelines. RMD Open, 2019,4(Suppl 1):e000787
Topiwala K, Hampton C, Boland C, et al. Neurologic IgG4-Related Disease. Neurohospitalist, 2019,9(2):118–119
García-Curdi F, Lois-Ortega Y, Gonzales-Sejas AG, et al. IgG4 related disease with exclusive sinonasal involvement: A case report and literature review. Rev Esp Patol, 2019,52(2):125–129
Kottahachchi D, Topliss DJ. Immunoglobulin G4-Related Thyroid Diseases. Eur Thyroid J, 2016,5(4):231–239
Kamisawa T, Zen Y, Nakazawa T, et al. Advances in IgG4-related pancreatobiliary diseases. Lancet Gastroenterol Hepatol, 2018,3(8):575–585
Yamada K, Yamamoto M, Saeki T, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther, 2017, 19(1):262–272
Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford), 2015,54(11):1982–1990
Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore), 2015,94(15):e680
Fernandez-Codina A, Martinez-Valle F, Pinilla B, et al. IgG4-Related Disease: Results From a Multicenter Spanish Registry. Medicine (Baltimore), 2015,94(32): e1275
Ebbo M, Daniel L, Pavic M, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore), 2012,91(1):49–56
Campochiaro C, Ramirez GA, Bozzolo EP, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol, 2016,45(2):135–145
Chen H, Lin W, Wang Q, et al. IgG4-related disease in a Chinese cohort: a prospective study. Scand J Rheumatol, 2014,43(1):70–74
Sato Y, Takeuchi M, Takata K, et al. Clinicopathologic analysis of IgG4-related skin disease. Mod Pathol, 2013,26(4):523–532
Yokoe T, Hayashida T, Kikuchi M, et al. IgG4-related mastopathy: A case report and literature review. Clin Case Rep, 2018,6(8):1549–1553
Khosroshahi A, Wallace ZS, Crowe JL, et al. Second international symposium on IgG4-related disease. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol, 2015,67(7):688–699
Shirakashi M, Yoshifuji H, Kodama Y, et al. Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study. Sci Rep, 2018,8(1):10 262
Author information
Authors and Affiliations
Corresponding authors
Additional information
Conflict of Interest Statement
The authors declare that there are no conflicts of interest.
Rights and permissions
About this article
Cite this article
Pan, Yy., Zhou, Sc., Wang, Yj. et al. IgG4-Related Disease: A Retrospective Chinese Study of Features and Treatment Response of 98 Patients Including 4 Rare Cases. CURR MED SCI 41, 390–397 (2021). https://doi.org/10.1007/s11596-021-2359-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-021-2359-5